Analyst Moves: MJN, INTC, MTN

This morning, Oppenheimer upgraded shares of Mead Johnson (MJN) from perform to outperform as the changes to China's one child policy should provide a tailwind for its infant formula sales. With the upgrade, Oppenheimer set a $100 price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.